Bevacizumab (Avastin) — anti-VEGF treatment for selected solid tumors

What bevacizumab is in simple patient language

Avastin — brand name. Bevacizumab — the drug name in medical records. An antibody drip. Not a home tablet. Not a treatment to add just because the cancer name is on a list.

Why it comes up: many tumors need new small vessels around them. Those vessels bring food and oxygen. Bevacizumab is used to press down part of that vessel signal.

The drug is usually placed next to another plan, not thrown in alone. The doctor looks at the tumor type, scans, past treatment, pressure, urine protein, kidney values, bleeding history, clots, wounds, surgery plans, bowel risks, and the patient’s strength. Avastin can be useful. It can also be the wrong idea when the risks are too high.

How bevacizumab works

A tumor can send messages that ask the body to build more blood vessels. One of the main messages is called VEGF. Bevacizumab catches that message before it can keep pushing the vessel system.

In plain language: the tumor gets less help from new vessels. That may slow growth. It may help another treatment work for longer. It does not mean every spot disappears quickly.

Normal vessels matter too. That is why this drug is tied to pressure checks, urine checks, bleeding questions, wound healing, clot symptoms, and belly pain. The vessel signal is not only a tumor issue.

Which diseases bevacizumab may be used for

Bevacizumab is discussed in several solid cancers. Still, the diagnosis line alone is not enough. The clinical setting has to fit.

• bowel or rectal cancer that has spread, usually inside a wider drug plan;
• some lung cancers of the non-small-cell type, when the tumor features and bleeding risk allow it;
• ovary, fallopian tube, or peritoneal cancer at selected points in treatment;
• cervix cancer when the disease has spread, returned, or stopped answering older treatment;
• kidney cancer in selected systemic plans;
• some liver or brain tumor situations when the oncology team has a clear reason;
• second opinion when Avastin was offered and the patient needs to understand why.

Same drug, different job. In one plan it is used with chemotherapy. In another it may be part of maintenance. In a third, it is avoided because of bleeding, wounds, pressure, or bowel danger.

When bevacizumab can be especially relevant

The useful question is not “Is Avastin strong?” The useful question is: what is it supposed to do in this exact plan?

• the disease needs treatment for the whole body;
• the doctor wants to add a vessel-targeting part to the main scheme;
• the goal is to keep the disease quieter for longer;
• the chosen treatment already has a place where Avastin can fit;
• the patient was told about Avastin but does not understand the reason;
• the risk check has not yet been done clearly.

A modern-sounding name is not enough. Pressure that runs high, recent surgery, blood loss, clots, kidney trouble, bowel inflammation, or an open wound can change the answer completely.

What needs to be checked before treatment

Before the first drip, the doctor needs more than a short note from the file. Avastin decisions are partly about cancer control and partly about safety.

• the exact cancer type and stage;
• what treatment has already been used and what happened on it;
• fresh scans, with older scans for comparison;
• blood pressure readings and current pressure medicines;
• urine protein and kidney function;
• blood count and blood chemistry;
• past bleeding, clots, stroke, heart attack, or vessel problems;
• recent surgery, dental procedures, wounds, stitches, or planned operations;
• belly pain history, bowel inflammation, fistula risk, or past perforation;
• blood thinners and other regular medicines.

Sometimes the safest step is not to start today. Control the pressure first. Let the wound close. Explain the bleeding. Check the urine again. That is not delay for paperwork. That is how avoidable trouble is reduced.

How treatment with bevacizumab goes

Bevacizumab is given through a vein in a clinic. The schedule follows the oncology plan. Often it sits beside chemotherapy or another systemic treatment. Sometimes it continues later as a quieter maintenance part.

During treatment the team keeps asking boring questions that are not boring at all: pressure, urine, headache, nosebleeds, swelling, breathing, chest pressure, belly pain, wound healing, and general strength.

If a problem appears, the drug is not always lost. The doctor may pause it, treat the pressure, repeat urine tests, delay an infusion, or ask for urgent assessment. What should not happen: the patient deciding alone to push through because the date of the next drip is already booked.

Possible side effects

People do not react the same way. Some have little trouble. Others run into a pressure issue, urine changes, bleeding, clot symptoms, or a wound problem.

• blood pressure going up;
• protein showing in urine;
• kidney strain in blood or urine tests;
• nosebleeds or other bleeding;
• clot-type problems, including pain or swelling in a leg;
• chest pressure, sudden weakness, or stroke-like symptoms;
• slow wound healing after surgery, injury, or dental work;
• belly pain, with rare but serious bowel damage or fistula;
• headache, swelling, tiredness;
• reaction during the drip: chills, heat, rash, breathing trouble, or chest discomfort.

Small changes can matter here. A bit of blood. A wound that should have closed. Pressure numbers creeping up. New belly pain. These are not details to save for “next time”.

When the treating team needs to know fast

Do not wait at home with symptoms that may point to bleeding, clotting, bowel trouble, pressure crisis, or a wound problem.

• a severe headache, confusion, speech trouble, or one-sided weakness;
• pressure numbers that jump high or stay high despite the usual tablets;
• black stool, red blood, blood in urine, vomiting blood, or heavy nose bleeding;
• new breathing difficulty, chest tightness, or coughing blood;
• strong belly pain, a hard belly, fever, or sudden worsening;
• leg swelling or calf pain that is new and one-sided;
• fainting, sudden severe weakness, or a feeling that something is badly wrong;
• a wound opening, fluid from a surgical area, or poor healing;
• any rapid change that frightens the patient or family.

Do not try to prove at home whether Avastin caused it. The team should check. Early is safer than late.

Why bevacizumab is not right for everyone

This drug can be a useful part of treatment. It is not a universal add-on. The same cancer name can lead to different choices.

• active bleeding or a high bleeding risk;
• pressure that is not under control;
• recent surgery or a wound that has not healed;
• bowel conditions that make perforation or fistula more likely;
• recent clot, stroke, heart attack, or another serious vessel event;
• marked urine protein or kidney trouble;
• weak general condition where another drug may add more harm than benefit;
• a current treatment line where a different strategy makes better sense.

Choosing something else does not mean Avastin is a bad drug. It may simply be the wrong tool for this moment.

Can bevacizumab be combined with other treatments

Often, yes. Bevacizumab is commonly discussed as part of a larger scheme. But “more drugs” is not the goal. A combination needs a reason.

It may be used next to chemotherapy, sometimes next to another systemic approach, or later as a maintenance part. The exact plan depends on tumor type, treatment line, scans, symptoms, and safety checks.

Surgery needs special planning. Wounds need time. Dental procedures may matter too. Around operations the oncologist decides when to stop and when it is safe to return. Guessing those dates is not a patient’s job.

What no quick response can mean

With bevacizumab, the “answer” is not always a dramatic scan after the first cycles. Sometimes the useful result is slower movement of the disease. Sometimes symptoms stay steadier. Sometimes the main scheme works better with the vessel part beside it.

The doctor reads scans together with symptoms, pressure, urine, kidney values, side effects, and quality of life. One picture alone can mislead. One good day can mislead too.

If the disease keeps growing, if toxicity becomes heavy, or if a safety risk appears, the plan must be discussed again. That is not panic. That is normal oncology work.

Oncology consultation in Israel about bevacizumab

At Tel Aviv Medical Clinic, the discussion is not “Can we add Avastin?” in the abstract. The point is to understand whether bevacizumab has a real place in this patient’s plan.

The consultation can review the diagnosis, scans, previous treatment, pressure history, urine results, kidney function, bleeding or clot risks, surgery dates, wounds, and regular medicines. The family can also prepare clear questions for the treating oncologist.

We do not prescribe treatment remotely and we do not replace the treating doctor. We help organize the medical story, check the logic of the proposed step, and understand what should be clarified before the next decision.

Frequently asked questions — answered by Dr. Stefanska

1. Is bevacizumab chemotherapy?

No. Avastin is not the usual kind of chemotherapy. It does not work by attacking all fast-dividing cells. It goes after the vessel signal around the tumor.

Still, I would not call it “soft” treatment. Pressure, urine, bleeding, wounds, clots, and belly symptoms all matter. A drug can be non-chemo and still need serious follow-up.

2. Why is Avastin often added to another treatment?

Because it usually has a supporting job. It is often there to make the main plan stronger or to help hold the disease steadier. It is not just a decoration beside chemotherapy.

I always want to know the reason for the add-on. What is the tumor? What line of treatment is this? What are we trying to gain? And what risk are we accepting for that gain?

3. Why do pressure and urine tests matter so much?

Because this drug works around blood vessels, and the body has vessels everywhere. Pressure can rise. The kidneys can start showing stress through urine protein.

The patient may feel fine while the numbers are already changing. That is why I do not treat these checks as routine paperwork. They are part of the safety plan.

4. Can bevacizumab be started right after surgery?

Not automatically. Avastin can interfere with normal healing. I would want to know the operation date, how the wound looks, whether there were complications, and whether another procedure is planned.

Sometimes waiting is the wiser choice. Starting too early can turn a healing issue into a much bigger problem.

5. Which symptoms should not wait at home?

Heavy bleeding. A severe headache. Very high pressure. New chest tightness. Breathing trouble. Strong belly pain. One-sided weakness. Speech trouble. A wound that opens or leaks.

Those are not “watch until Monday” symptoms. Maybe the cause is not Avastin. Fine. Let the doctor check and say that.

6. What should I prepare for a consultation about Avastin?

Bring the diagnosis, pathology, recent scans, old scans for comparison, treatment list, blood tests, urine test, pressure readings, kidney values, and information about surgery or wounds.

A short timeline helps a lot: when the cancer was found, what was given, what worked, what stopped working, and why Avastin is now being discussed.

7. If Avastin is stopped because of risk, is the plan worse?

Not necessarily. Sometimes stopping or pausing is the safer decision. Bleeding, uncontrolled pressure, a fresh operation, a wound, or a clot risk can make the price too high.

The goal is not to use the strongest-sounding drug. The goal is to choose a plan the patient can actually pass through with a reasonable balance of benefit and danger.

Important information

This material is general medical information. It is not a prescription and not a personal treatment plan. Bevacizumab can be discussed only after review of the diagnosis, scans, previous treatment, blood pressure, urine protein, kidney function, bleeding risk, surgery history, wounds, medicines, and overall condition.

Do not start, stop, or change treatment without the treating doctor.

Contacts

For a consultation about Bevacizumab:
📞 +972-73-374-6844
📧 [email protected]
💬 WhatsApp: +972-52-337-3108